Genocea Biosciences GNCA

$ 0.05 -15.0%

Quarterly report 2022-Q1
added 12-23-2023

Genocea Biosciences Income Statement 2011-2024 | GNCA

Annual Income Statement Genocea Biosciences

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	72.7 M	124 M	42.7 M	47.9 M	26.1 M	123 M	76.1 M	134 M	-	-	-
Shares	68.6 M	44.4 M	20.6 M	10.3 M	3.58 M	3.54 M	3.06 M	1.95 M	-	-	-
Historical Prices	1.06	2.8	2.07	4.64	7.28	35.4	24.9	68.6	-	-	-
Net Income	-33.2 M	-43.7 M	-39 M	350 K	-56.7 M	-49.6 M	-42.5 M	-35.3 M	-20.8 M	-13.4 M	-14.7 M
Revenue	1.64 M	1.36 M	-	-	-	235 K	670 K	308 K	731 K	1.98 M	1.82 M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	1.36 K	-	-	-	-	-	-	-	-	-
Operating Income	-52.1 M	-47 M	-39 M	-39.5 M	-55.3 M	-48.2 M	-41.4 M	-33.2 M	-19.9 M	-13 M	-
Interest Expense	1.12 M	1.38 M	946 K	1.02 M	1.44 M	1.74 M	1.28 M	1.02 M	-	-	-
EBITDA	-50.5 M	-45.9 M	-37.9 M	-38.4 M	-51.1 M	-46.4 M	-40.3 M	-32.7 M	-19.6 M	-12.7 M	-14.4 M
Operating Expenses	53.7 M	48.3 M	39 M	39.5 M	52.6 M	48.5 M	42 M	33.5 M	20.7 M	14.9 M	16.5 M
General and Administrative Expenses	14.7 M	14.4 M	12 M	14.3 M	13.4 M	15.4 M	14 M	9.75 M	4.96 M	3.69 M	3 M

All numbers in USD currency

Quarterly Income Statement Genocea Biosciences

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	71.1 M	58.2 M	69.8 M	68 M	66.2 M	53 M	55.5 M	29.1 M	28.1 M	27.6 M	26.7 M	15.3 M	12.7 M	10.8 M	10.8 M	10.7 M	71.2 M	28.7 M	28.7 M	28.5 M	28.5 M	28.4 M	28.4 M	28.3 M	28.2 M	28.1 M	26.6 M	24.2 M	18.8 M	17.7 M	17.5 M	17.3 M	9.86 M	300 K	296 K	296 K	296 K	-	-	-	-	-	-	-	-
Net Income	-	-	-	-16 M	-	-3.62 M	-4.31 M	-12 M	-	-4.56 M	-11.3 M	-12.9 M	-9.36 M	-7.53 M	-6.5 M	-15.6 M	350 K	-7.83 M	-4.44 M	-15.9 M	-10.7 M	-16.9 M	-15.4 M	-13.7 M	-16 M	-12.8 M	-11 M	-9.75 M	-10.3 M	-9.77 M	-10.3 M	-12.1 M	-11.6 M	-9.17 M	-7.15 M	-7.33 M	-6.35 M	-4.84 M	-4.96 M	-4.66 M	-	-	-	-	-	-	-	-
Revenue	-	-	-	270 K	-	1.64 M	-	-	-	453 K	906 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	308 K	-	-	-	20 K	224 K	228 K	259 K	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-15.8 M	-	-11.7 M	-14.5 M	-12.4 M	-	-10.7 M	-11.2 M	-13.4 M	-	-9.58 M	-10.1 M	-9.48 M	-	-10.5 M	-9.79 M	-10.4 M	-	-16.5 M	-15 M	-13.4 M	-	-12.4 M	-10.7 M	-9.43 M	-	-9.49 M	-10 M	-11.8 M	-	-8.96 M	-6.91 M	-6.37 M	-	-4.48 M	-4.75 M	-4.53 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	231 K	-	290 K	282 K	279 K	-	377 K	365 K	259 K	-	154 K	299 K	302 K	-	266 K	241 K	201 K	-	366 K	370 K	359 K	-	438 K	430 K	431 K	-	320 K	307 K	319 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-15.4 M	-	-11.7 M	-14.5 M	-12 M	-	-9.87 M	-10.6 M	-13.1 M	-	-8.76 M	-9.52 M	-9.2 M	-	-9.64 M	-9.24 M	-10.1 M	-	-15.3 M	-14.1 M	-12.9 M	-	-11.1 M	-9.88 M	-9.07 M	-	-8.83 M	-9.64 M	-11.6 M	-	-8.66 M	-6.75 M	-6.3 M	-	-4.24 M	-4.58 M	-4.44 M	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	16 M	-	13.4 M	14.5 M	12.4 M	-	11.2 M	12.1 M	13.4 M	9.86 M	9.58 M	10.1 M	9.48 M	8.89 M	10.5 M	9.79 M	10.4 M	10.4 M	16.5 M	15 M	13.4 M	15.7 M	12.4 M	10.7 M	9.66 M	10.3 M	9.7 M	10.1 M	11.9 M	11.2 M	8.96 M	6.91 M	6.37 M	6.19 M	4.7 M	4.98 M	4.79 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	3.6 M	-	3.88 M	4.03 M	3.67 M	-	3.64 M	3.48 M	3.39 M	-	2.76 M	3.22 M	3.02 M	-	4.1 M	4.47 M	3.11 M	-	3.75 M	3.57 M	3.63 M	-	3.62 M	4.03 M	3.92 M	-	3.64 M	3.17 M	3.39 M	-	2.84 M	2.36 M	1.97 M	-	1.42 M	879 K	810 K	-	-	-	-	-	-	-	-

All numbers in USD currency